iXpressGenes, Inc. — Form D
iXpressGenes, Inc. of HUNTSVILLE, AL, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-26. The offering totals $4.2M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-26
- Form: D
- Accession: 0002074283-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.2M
- Amount sold: $2.4M
- Remaining: $1.8M
- Investors: 13
- Date of first sale: 2009-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-549995
Issuer
- Name: iXpressGenes, Inc.
- CIK: 0002074283
- Entity type: Corporation
- Jurisdiction: ALABAMA
- Address: 601 GENOME WAY NORTHWEST, HUNTSVILLE, AL, 35806
- Phone: (256) 327-9750
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Barbara Fisk | Director | Huntsville, AL |
| Joseph Ng | Director | Huntsville, AL |
| Peggy Sammon | Director | Huntsville, AL |
| John Schmitt | Director | Huntsville, AL |
| Joseph Ng | Executive Officer | Huntsville, AL |
| John Schmitt | Executive Officer | Huntsville, AL |
More